Vivanza Biosciences: Audited Results, MD & CS Resignations
Vivanza Biosciences Ltd. announced audited standalone financial results for the quarter and year ended March 31, 2026. The board approved the results and noted the resignations of Hemant A. Parikh as a Non-Executive Director (effective March 17, 2026) and Chaitra Arora as Company Secretary & Compliance Officer (effective April 30, 2026). The board also approved the reconstitution of various committees, including the Audit Committee and Nomination & Remuneration Committee, effective May 7, 2026.
Key Highlights
- Audited standalone financial results for Q4 and FY26 approved.
- Hemant A. Parikh resigned as Non-Executive Director effective March 17, 2026.
- Chaitra Arora resigned as Company Secretary & Compliance Officer effective April 30, 2026.
- Board committees reconstituted effective May 7, 2026.
- Shivam Soni & Co. issued an audit opinion on the standalone financial results.
Price Impact
More from VIVANZA
Vivanza Biosciences Board Meeting on Aug 1 to Approve Q1 FY27 Results
Vivanza Biosciences: Auditor Issues Unmodified Opinion on Audited Financials
Vivanza Biosciences Board Approves Share Transfer and Appoints Company Secretary